Debabrata Mukhopadhyay, PhD

  • 14904 Citations
  • 61 Scopus h-Index
1991 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Debabrata Mukhopadhyay is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Vascular Endothelial Growth Factor A Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Neuropilin-1 Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Endothelial cells Chemical Compounds
Endothelial Cells Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1998 2020

Tumor Microenvironment
Cell Biology
Extracellular Matrix
Pancreatic Neoplasms

Mayo Clinic SPORE in Pancreatic Cancer

Cohen, P. A., Urrutia, R. A., De Andrade, M., Chari, S. T., Lingle, W. L., Billadeau, D. D., Petersen, G. M., Couch, F. J., Mukhopadhyay, D., Chini, E. N., Smyrk, T. C., Oberg, A. L., Gendler, S. J., Couch, F. J., Mukherjee, P., Mukherjee, P., Andrade, M., Fernandez-Zapico, M. E. & Billadeau, D. D.

National Institutes of Health


Project: Research project

Pancreatic Neoplasms
Glycogen Synthase Kinase 3
Neurotransmitter Agents
Vascular Endothelial Growth Factor A
Dopamine D2 Receptors

Research Output 1991 2020

Molecular inhibitor of QSOX1 suppresses tumor growth in vivo

Fifield, A. L., Hanavan, P. D., Faigel, D. O., Sergienko, E., Bobkov, A., Meurice, N., Petit, J. L., Polito, A., Caulfield, T. R., Castle, E. P., Copland, J. A., Mukhopadhyay, D., Pal, K., Dutta, S. K., Luo, H., Ho, T. H. & Lake, D. F., Jan 1 2020, In : Molecular cancer therapeutics. 19, 1, p. 112-122 11 p.

Research output: Contribution to journalArticle

sulfhydryl oxidase
Enzyme Assays
Renal Cell Carcinoma

Ovatodiolide suppresses oral cancer malignancy by down-regulating exosomal mir-21/STAT3/β-catenin cargo and preventing oncogenic transformation of normal gingival fibroblasts

Chen, J. H., Wu, A. T. H., Bamodu, O. A., Yadav, V. K., Chao, T. Y., Tzeng, Y. M., Mukhopadhyay, D., Hsiao, M. & Lee, J. C., Jan 2020, In : Cancers. 12, 1, 56.

Research output: Contribution to journalArticle

Open Access
STAT3 Transcription Factor
Mouth Neoplasms
Squamous Cell Carcinoma
4 Citations (Scopus)

AFM study: Cell cycle and probe geometry influences nanomechanical characterization of Panc1 cells

Kulkarni, T., Tam, A., Mukhopadhyay, D. & Bhattacharya, S., May 1 2019, In : Biochimica et Biophysica Acta - General Subjects. 1863, 5, p. 802-812 11 p.

Research output: Contribution to journalArticle

Cell Cycle
Cell Cycle Resting Phase

A novel multi-target small molecule, LCC-09, inhibits stemness and therapy-resistant phenotypes of glioblastoma cells by increasing MIR-34a and deregulating the DRD4/AKT/MTOR signaling axis

Wen, Y. T., Wu, A. T., Bamodu, O. A., Wei, L., Lin, C. M., Yen, Y., Chao, T. Y., Mukhopadhyay, D., Hsiao, M. & Huang, H. S., Oct 2019, In : Cancers. 11, 10, 1442.

Research output: Contribution to journalArticle

Open Access
Stem Cells
2 Citations (Scopus)

BRAF V600E-induced, tumor intrinsic PD-L1 can regulate chemotherapy-induced apoptosis in human colon cancer cells and in tumor xenografts

Feng, D., Qin, B., Pal, K., Sun, L., Dutta, S., Dong, H., Liu, X., Mukhopadhyay, D., Huang, S. & Sinicrope, F. A., Jan 1 2019, (Accepted/In press) In : Oncogene.

Research output: Contribution to journalArticle

Colonic Neoplasms
Drug Therapy